"AMNOG in a nutshell" eBook (2026 update!)
£37
AMNOG in a Nutshell
A 41-page practical guide answering the 10 most common questions pharma professionals ask about Germany’s AMNOG process.
Downloaded by over 400 people, now in its sixth iteration and updated for the latest BStabG changes, it covers the AMNOG process, key stakeholders, HTA outcomes, reimbursement rules, price setting, additional benefit, appropriate comparator therapy, re-assessments and orphan drug-specific considerations.
A concise reference for pharma professionals who need to understand German market access quickly and confidently.
J. Samuel
Really enjoy and rely on your content to inform myself. Thank you!
L. Rabadi
Thank you so much Anja for the very helpful, diverse yet focused, and easy to understand content.
E. Nedev
Thank you for this great online resource and your response! This is extremely helpful!
Anonymous
Firstly wanted to thank you for putting together such a comprehensive resource regarding German market access.
Gourishankar P.
I work in the Market Access domain. I want to express my profound gratitude to you for helping me understand the Market Access legislation in Germany. You have simplified it in the best possible manner! Thanks a billion!
Kawitha H.
I love getting your updates. The work you do is so important and helps many of us. A huge thank you.
Panos P.
I want to express my deepest gratitude for your amazing work in delineating the key parameters of the P&R landscape of Germany.